Mh. Elghouzzi et al., Hepatitis C virus: Routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors, VOX SANGUIN, 79(3), 2000, pp. 138-144
We evaluated and analysed risk factors of HCV-infected blood donors accordi
ng to HCV genotypes in order to improve the transfusion policy and safety o
f blood supply. Materials and Methods: HCV-RNA was analysed in sera from 51
8 anti-HCV-positive blood donors, who were invited to medical consultation
and interview as to risk factors by means of an extensive questionnaire. HC
V genotyping was done on all samples posi tive for HCV-RNA. Results: Of the
518 sera, 399 (77%) were HCV-RNA positive, and 394 of 399 HCV genotypes we
re identified. Major genotypes were 1b (34.3%), 3a (24%), 1a (19.5%) and 2
(11.4%). Of the donors, 289 (55.8%) were interviewed regarding their risk b
ehaviour: 27% were former intravenous drug users (IVDUs), 26% had been tran
sfused, 8% had a history of invasive diagnostic procedures, and 13% a histo
ry of surgery. Among the 224 interviewed donors, genotypes 1a and 3a were m
ainly associated with IVDU (51 and 45% respectively) and genotype 1b, with
transfusion and nosocomial infections (40 and 25%, respectively). Conclusio
n: In this population of anti-HCV-positive blood donors, nosocomial infecti
on may be a route of HCV spread, but the main risk factor remains IVDU, par
ticularly in young men. The transfusion policy will improve if predonation
interviews of such young men are done with a specific and sensitive questio
nnaire. Copyright (C) 2000 S.Karger AG,Basel.